|2012||20 years of Dr. Reddy’s in Russian market|
|2011||• Dr. Reddy’s enters into marketing and distribution agreement with Novartis (Famvir).
• Achievement of > USD 200mln sales in Russia.
|2010||• Dr. Reddy’s enters into licensing agreement with Cipla (Senade).
• Dr. Reddy’s enters into an agreement with R-Pharm of Russia – Collaboration in the areas of high
technology and knowledge sharing.
|2009||Achievement of > USD 150mln sales in Russia|
|2008||Achievement of > USD 100mln sales in Russia|
|2007||Dr. Reddy’s becomes 15th among Russian companies on retail market ( as per Pharmexpert data)|
|2006||Dr. Reddy’s enters into licensing agreement with MERCK AG (Germany), Molteni (Italy) and Torrent (India).|
|2005||Set-up OTC Field force|
|2004||Formed separate field force to strengthen work with hospitals|
|2003||Set-up Wholly Owned Subsidiary with pharmacy warehouse for better service on the territory of RF|
|2000||• Dr. Reddy’s increases territory of coverage: in Saratov, Volgograd, Stavropol, Chelyabinsk, Ufa,
Yekaterinburg, Kemerovo, Novokuznetsk.
• Nise becomes No 1 among nimesulides in RF.
|1998||• Despite of economical crisis in Russia Dr. Reddy’s decides to stay back and continues to work in Russia.
• Ciprolet becomes No 1 among ciprofloxacins in RF
|1997||Omez becomes No. 1 among omeprazoles in Russia|
|1992||Dr.Reddy’s enters Russian market. Set-up Representation office in Moscow. The business is focused on participation in tenders and state supplies.|